A Phase II Study of ACR-368 and Low Dose Gemcitabine in R/M HNSCC

Clinical trial NCT06597565 · RECRUITING

Trial details

NCT number: NCT06597565
Sponsor: H. Lee Moffitt Cancer Center and Research Institute
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Head and Neck Squamous Cell Carcinoma

Start date: 2024-09-25
Primary completion: 2028-08-23
Enrollment: 43

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.